Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 8, 2012, Pages

  de Angelis, Katia ^a   Senador, Danielle D ^b   Mostarda, Cristiano ^c   Irigoyen, Maria C ^c   Morris, Mariana ^b  

^a University Nove de Julho   (Brazil)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autonomic nervous system; Insulin resistance; Leptin; Metabolic syndrome; Radiotelemetry; Spectral analysis

Indexed keywords

ADIPONECTIN; DRINKING WATER; FRUCTOSE; LEPTIN; RESISTIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART RATE; HEART RATE VARIABILITY; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPATHETIC FUNCTION; TELEMETRY;

EID: 84859738703     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00450.2011     Document Type: Article

References (48)

1. Basciano H, Federico L, Adeli K. Fructose, insulin resistance and metabolic dyslipidemia. Nutr Metab 5: 1-14, 2005.
2. Bertinieri G, di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia GJ. A new approach to analysis of the arterial baroreflex. J Hypertens Suppl 3: S79-S81, 1985.
3. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, ang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462, 2000.
4. Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia 39: 1345-1350, 1996.
5. Brito JO, Ponciano K, Figueroa D, Bernardes N, Sanches IC, Irigoyen MC, De Angelis K. Parasympathetic dysfunction is associated with insulin resistance in fructose-fed female rats. Braz J Med Biol Res 41: 804-808, 2008.
6. Brown CM, Dulloo AG, Yepuri G, Montani JP. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 294: R730-R737, 2008.
7. Carnethon MR, Jacobs DR, Sidney S, Liu K. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care 26: 3035-3041, 2003.
8. Cunha TS, Farah V, Paulini J, Pazzine M, Elased KM, Marcondes FK, Cláudia Irigoyen M, De Angelis K, Mirkin LD, Morris M. Relationship between renal and cardiovascular changes in a murine model of glucose intolerance. Regul Pept 139: 1-4, 2007.
9. Dai S, McNeill JH. Fructose-induced hypertension in rats is concentrationand duration-dependent. J Pharmacol Toxicol Methods 33: 101-107, 1995.
10. De Angelis K, Irigoyen MC, Morris M. Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci 145: 3-10, 2008.
11. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957, 1996.
12. Elliot SS, Keim NL, Stern JS, Teff K, Havel PT. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76: 911-922, 2002.
13. Farah V, Elased KM, Chen Y, Key MP, Cunha TS, Irigoyen MC, Morris M. Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci 130: 41-50, 2006.
14. Farah V, Elased KM, Morris M. Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet. Am J Physiol Heart Circ Physiol 293: H1083-H1089, 2007.
15. Frattola A, Parati G, Cuspidi C, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 11: 1133-1137, 1993.
16. Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H. Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes 51: 893-900, 2002.
17. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, Mancia G. Metabolic syndrome and cardiometabolic risk: an update. Blood Press 18: 7-16, 2009.
18. Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 33: 1305-1312, 2008.
19. Hellstrom HR. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes-including reducing the risk of age and atherosclerosis. Med Hypotheses 68: 415-433, 2007.
20. Hsieh PS. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats. J Hypertens 23: 2209-2217, 2005.
21. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L. Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203: 1623-1628, 2006.
22. Janssen BJ, Leenders PJ, Smits JF. Short-term and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol 278: R215-R225, 2000.
23. Kamide K, Rakugi H, Higaki J, Okamura A, Nagai M, Moriguchi K, Ohishi M, Satoh N, Tuck ML, Ogihara T. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens 15: 66-67, 2002.
24. Katovich MJ, Reaves PY, Francis SC, Pachori AS, Wang HW, Raizada MK. Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension. J Hypertens 19: 1553-1558, 2001.
25. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36: 901-906, 2000.
26. Kreier F, Fliers E, Voshol PJ, Van Eden CG, Havekes LM, Kalsbeek A, Van Heijningen CL, Sluiter AA, Mettenleiter TC, Romijn JA, Sauerwein HP, Buijs RM. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J Clin Invest 110: 1243-1250, 2002.
27. Kreier F, Yilmaz A, Kalsbeek A, Romijn JA, Sauerwein HP, Fliers E, Buijs RM. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. Diabetes 52: 2652-2656, 2003.
28. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288: H2031-H2041, 2005.
29. Lee YC, Ko YH, Hsu YP, Ho LT. Plasma leptin response to oral glucose tolerance and fasting/re-feeding tests in rats with fructose-induced metabolic derangements. Life Sci 78: 1155-1162, 2006.
30. Lichnovská R, Gwozdziewiczová S, Chlup R, Hrebícek J. Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149: 119-126, 2005.
31. Lindmark S, Wiklund U, Bjerle P, Eriksson JW. Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects. Diabet Med 20: 399-405, 2003.
32. Luo D, Hou X, Hou L, Wang M, Xu S, Dong C, Liu X. Effect of pioglitazone on altered expression of A metabolism-associated molecules in the brain of fructose-drinking rats, a rodent model of insulin resistance. Eur J Pharmacol 664: 14-19, 2011.
33. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482-492, 1991.
34. Merat S, Casanada F, Sutphin M, Palinski W, Reaven PD. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19: 1223-1230, 1999.
35. Miller AW, Sims JJ, Canavan A, Hsu T, Ujhelyi MR. Impaired vagal reflex activity in insulin-resistant rats. J Cardiovasc Pharmacol 33: 698-702, 1999.
36. Morris M, Araujo IC, Pohlman RL, Marques MC, Rodwan NS, Farah VM. Timing of fructose intake: an important regulator of adiposity. Clin Exp Pharmacol Physiol 39: 57-62, 2012.
37. Pagani M, Malfatto G, Pierini Casati R S, Masu AM, Poli M, Guzzetti S, Lombardi F, Cerutti S, Malliani A. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst 23: 143-153, 1988.
38. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5: 93-98, 1987.
39. Ribeiro RT, Lautt WW, Legare DJ, Macedo MP. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia 48: 976-983, 2005.
40. Sakar Y, Nazaret C, Lettéron P, Ait Omar A, Avenati M, Viollet B, Ducroc R, Bado A. Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents. PLos One 4: e7935, 2009.
41. Senador D, Key M, Brosnihan KB, Irigoyen MC, Elased KM, Morris M. Cardiovascular interactions between losartan and fructose in mice. J Cardiovasc Pharmacol Ther 15: 68-77, 2010.
42. Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 295: R1370-R1375, 2008.
43. Stauss HM, Mrowka R, Nafz B, Patzak A, Unger T, Persson PB. Does low frequency power of arterial blood pressure reflect sympathetic tone? J Auton Nerv Syst 54: 145-154, 1995.
44. Tank J, Jordan J, Diedrich A, Obst M, Plehm R, Luft FC, Gross V. Clonidine improves spontaneous baroreflex sensitivity in conscious mice through parasympathetic activation. Hypertension 43: 1042-1047, 2004.
45. Valensi P, Nguyen TN, Idriss S, Cazes P, Karam G, Paries J, Miossec P, Attali JR. Influence of parasympathetic dysfunction and hyperinsulinemia on the hemodynamic response to an isometric exercise in non-insulin-dependent diabetic patients. Metabolism 47: 934-939, 1998.
46. Van Gaal LF, Mertens IL, De Block DE. Mechanisms linking obesity with cardiovascular disease. Nature 444: 875-880, 2006.
47. Verma S, Bhanot S, Mcneill JH. Sympathectomy prevents fructoseinduced hyperinsulinemia and hypertension. Eur J Pharmacol 373: R1-R4, 1999.
48. Wiernsperger N, Geloen A, Rapin JR. Fructose and cardiometabolic disorders: the controversy will, and must, continue. Clinics 65: 729-738, 2010.